Actively Recruiting
Observational Study to Measure Adenoviral Antibodies and Inflammatory Cytokines in People With Chronic Granulomatous Disease
Led by Ensoma · Updated on 2026-08-17
60
Participants Needed
52
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research study focuses on both adult and pediatric participants diagnosed with Chronic Granulomatous Disease CGD. The main goal is to understand how common specific antibodies and inflammatory cytokines are in people living with CGD by measuring these markers in their blood. Participants will have blood samples collected to measure levels of adenovirus-specific antibodies and inflammatory cytokines. This is an observational study, meaning no treatments are given instead, the study observes and records these blood markers to characterize their prevalence in this patient group. During the study, participants will provide blood samples for laboratory analysis of antibody titers and cytokine levels. The main outcomes measured include total adenoviral-specific antibody levels and neutralizing antibody levels, along with inflammatory cytokine concentrations. The study is expected to be completed by December 2026.
CONDITIONS
Brief Title
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Research Team
A
Andrew Dietz, MD, MSCR
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here